SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

RBC Capital Initiates Coverage On bluebird bio with Outperform Rating, Announces Price Target of $100

RBC Capital initiates coverage on bluebird bio (NASDAQ:BLUE) with a Outperform rating and announces Price Target of $100.

Benzinga · 05/13/2020 09:05

RBC Capital initiates coverage on bluebird bio (NASDAQ:BLUE) with a Outperform rating and announces Price Target of $100.